All posts by: Michael Zand

About Michael Zand

Stem cells: Japan’s scientific ‘moonshot’ – Financial Times – Financial Times

Continue reading

2017-09-04 NEWS

Financial Times

Stem cells: Japan’s scientific ‘moonshot’ – Financial Times
Financial Times
In mid-2008, when every headline was screaming market meltdown and the end of financial life as the world knew it, Hiromitsu Nakauchi spotted an old friend at …

and more »

Continue reading

2017-09-04 NEWS

PLoS Blogs (blog)

National academies’s initial report on biodefense & synbio
PLoS Blogs (blog)
The National Academies of Sciences, Engineering, and Medicine are working to develop a report on security concerns around synthetic biology. The committee recently put out its initial report, “A Proposed Framework For Identifying Potential Biodefense …

Continue reading

2017-09-04 NEWS

Futurism

A “Fourth-Generation” DNA Base Editor Could Replace CRISPR
Futurism
The latest news in genetic science has been dominated by the CRISPR/Cas9 technique over the past five years. But a new “fourth-generation” DNA base editor could see CRISPR dethroned, according to a recent study published in Science Advances.

Continue reading

2017-09-04 NEWS

Futurism

A “Fourth-Generation” DNA Base Editor Could Replace CRISPR
Futurism
The latest news in genetic science has been dominated by the CRISPR/Cas9 technique over the past five years. But a new “fourth-generation” DNA base editor could see CRISPR dethroned, according to a recent study published in Science Advances.

Continue reading

2017-09-04 NEWS

FDA crackdown on unproven stem cell therapies
BioNews
The US Food and Drug Administration (FDA) has announced its intention to investigate the use of unproven stem cell therapies being offered in the country’s clinics. Tighter enforcement from the FDA comes as an inspection at StemImmune Inc based in San …

Continue reading

2017-09-04 NEWS

FDA crackdown on unproven stem cell therapies
BioNews
The US Food and Drug Administration (FDA) has announced its intention to investigate the use of unproven stem cell therapies being offered in the country’s clinics. Tighter enforcement from the FDA comes as an inspection at StemImmune Inc based in San …